$TDACU
Translational Development Acquisition Corp.
Nasdaq · Blank Checks · New York, NY
TDACU chart
What traders are saying about $TDACU
Latest postsTranslational Development Acquisition Corp. news
- Translational Development Acquisition Corp. Estimates – NASDAQ:TDAC
TradingView ·
- ProLogium Appoints Antony Sheriff, CEO of Rimac Group, to Board of Directors
Yahoo Finance ·
- ProLogium and Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment to Support Proposed Business Combination
Yahoo Finance ·
- TDAC Announces ProLogium's Filing of F-4 As Continuing Momentum Towards Merger
Yahoo Finance ·
- TDAC Announces Very Successful Share Redemption Results in Connection with Extension Vote
Yahoo Finance ·
Translational Development Acquisition Corp. key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net income | $6.4M | -$71,012 | -$485,550 |
| Total assets (year end) | $181.7M | $175.0M | $2,021 |
| Cash and equivalents (year end) | $29,787 | $438,174 | $2,021 |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Translational Development Acquisition Corp.
- Ticker
- TDACU (Nasdaq)
- Industry
- Blank Checks
- Headquarters
- New York, NY
- Fiscal year end
- December 31
- SEC CIK
- 1926599
Frequently asked questions
What exchange is Translational Development Acquisition Corp. listed on?
Translational Development Acquisition Corp. trades on the Nasdaq under the ticker symbol TDACU.
What industry is Translational Development Acquisition Corp. in?
Translational Development Acquisition Corp. is classified by the SEC under "Blank Checks".
Where is Translational Development Acquisition Corp. headquartered?
Translational Development Acquisition Corp.'s business address on file with the SEC is in New York, NY.
When does Translational Development Acquisition Corp.'s fiscal year end?
Translational Development Acquisition Corp.'s fiscal year ends on December 31.